title: AAV-mediated gene therapy for heart failure: enhancing contractility and calcium handling.
abstract: Heart failure is a progressive, debilitating disease that is characterized by inadequate contractility of the heart. With an aging population, the incidence and economic burden of managing heart failure are anticipated to increase substantially. Drugs for heart failure only slow its progression and offer no cure. However, results of recent clinical trials using recombinant adeno-associated virus (AAV) gene delivery offer the promise, for the first time, that heart failure can be reversed. The strategy is to improve contractility of cardiac muscle cells by enhancing their ability to store calcium through increased expression of the sarco(endo)plasmic reticulum Ca(2+)-ATPase pump (SERCA2a). Preclinical trials have also identified other proteins involved in calcium cycling in cardiac muscle that are promising targets for gene therapy in heart failure, including the following: protein phosphatase 1, adenylyl cyclase 6, G-protein-coupled receptor kinase 2, phospholamban, SUMO1, and S100A1. These preclinical and clinical trials represent a "quiet revolution" that may end up being one of the most significant and remarkable breakthroughs in modern medical practice. Of course, a number of uncertainties remain, including the long-term utility and wisdom of improving the contractile performance of "sick" muscle cells. In this regard, gene therapy may turn out to be a way of buying additional time for actual cardiac regeneration to occur using cardiac stem cells or induced pluripotent stem cells.
authors: Department of Pharmacology and Toxicology, School of Medicine and The Jackson Center for Heart Research Jackson, Mississippi USA ; The Cardiovascular-Renal Research Center, The University of Mississippi Medical Center Jackson, Mississippi USA.
authors: Fouad A
authors: FA
authors: Zouein
authors: George W
authors: GW
authors: Booz
references: J Gene Med. 2010 Jan;12(1):22-34
references: 19830780
references: Circulation. 2012 Jan 3;125(1):e2-e220
references: 22179539
references: Circulation. 2009 Jan 6;119(1):89-98
references: 19103992
references: Hum Gene Ther Methods. 2012 Aug;23(4):234-41
references: 22966786
references: Cardiovasc Res. 2005 Sep 1;67(4):678-88
references: 15927173
references: J Card Fail. 2009 Apr;15(3):171-81
references: 19327618
references: Gene Ther. 2012 Jun;19(6):606-12
references: 22534469
references: Am J Med Sci. 2011 Aug;342(2):120-4
references: 21747279
references: Nature. 2011 Sep 28;477(7366):546-7
references: 21956327
references: Ital J Pediatr. 2012 Sep 12;38:41
references: 22971785
references: Circulation. 2000 Nov 7;102(19):2396-401
references: 11067795
references: Circ Res. 2005 Dec 9;97(12):1314-22
references: 16269653
references: J Thorac Cardiovasc Surg. 2012 Mar;143(3):720-726.e3
references: 22143102
references: J Gene Med. 2005 Sep;7(9):1172-7
references: 15880449
references: Circ Heart Fail. 2010 Sep;3(5):627-34
references: 20634484
references: Am J Physiol Heart Circ Physiol. 2003 Dec;285(6):H2373-81
references: 14613911
references: J Am Coll Cardiol. 2008 Mar 18;51(11):1112-9
references: 18342232
references: J Clin Invest. 2004 Dec;114(11):1550-63
references: 15578088
references: PLoS One. 2012;7(4):e35875
references: 22558250
references: Circulation. 2004 Jul 20;110(3):330-6
references: 15249510
references: Nature. 2011 Sep 07;477(7366):601-5
references: 21900893
references: Heart Lung Circ. 2012 Sep;21(9):532-42
references: 22658631
references: J Gene Med. 2008 Feb;10(2):132-42
references: 18064719
references: Cardiovasc Res. 2011 Jan 1;89(1):79-88
references: 20675715
references: Genet Vaccines Ther. 2008 Sep 23;6:13
references: 18811960
references: Gene Ther. 2012 Jun;19(6):659-69
references: 22418063
references: Expert Rev Cardiovasc Ther. 2012 Aug;10(8):1023-37
references: 23030292
references: Mol Ther. 2012 Aug;20(8):1508-15
references: 22828502
references: Ann N Y Acad Sci. 2012 Apr;1254:42-50
references: 22548568
references: Gene Ther. 2012 Jun;19(6):686-93
references: 22336718
references: J Cardiovasc Transl Res. 2013 Apr;6(2):253-62
references: 23208013
references: Eur J Heart Fail. 2008 Jan;10(1):47-54
references: 18096433
references: J Virol. 2001 Jul;75(13):6199-203
references: 11390622
references: Nat Med. 2002 Aug;8(8):864-71
references: 12134142
references: J Clin Invest. 2013 Jan;123(1):37-45
references: 23281408
references: J Mol Cell Cardiol. 2007 Apr;42(4):852-61
references: 17300800
references: J Bioenerg Biomembr. 2005 Dec;37(6):375-80
references: 16691468
references: Eur Heart J. 2013 Jun;34(23):1714-22
references: 23536610
references: Circ Res. 2012 Jun 8;110(12):1646-60
references: 22679139
references: Curr Hypertens Rep. 2012 Dec;14(6):510-6
references: 22986910
references: Annu Rev Cell Dev Biol. 2012;28:719-41
references: 23057748
references: J Am Coll Cardiol. 2007 Jul 17;50(3):253-60
references: 17631218
references: Am J Physiol Heart Circ Physiol. 2013 Jan 15;304(2):H260-8
references: 23144315
references: Gene Ther. 2007 Jul;14(13):989-97
references: 17251988
references: Circ Heart Fail. 2013 May;6(3):606-19
references: 23616602
references: Am J Physiol Heart Circ Physiol. 2004 Jul;287(1):H172-7
references: 15001445
references: Sci Transl Med. 2011 Jul 20;3(92):92ra64
references: 21775667
references: J Clin Invest. 2013 Jan;123(1):62-70
references: 23281411
references: Gene Ther. 2003 Dec;10(26):2105-11
references: 14625564
references: FASEB J. 2006 Jun;20(8):1197-9
references: 16627625
references: Hum Gene Ther. 2006 Oct;17(10):1043-8
references: 17007567
references: Circulation. 2007 May 15;115(19):2506-15
references: 17470693
references: Circulation. 2011 Jul 19;124(3):304-13
references: 21709064
references: J Am Coll Cardiol. 2011 May 3;57(18):1846-55
references: 21527160
references: Blood. 2005 Feb 15;105(4):1424-30
references: 15507527
references: Can J Physiol Pharmacol. 2012 Aug;90(8):1017-28
references: 22784385
references: Gene Ther. 2008 Dec;15(23):1550-7
references: 18650850
references: Circulation. 2001 Mar 6;103(9):1311-6
references: 11238278
references: Eur J Heart Fail. 2011 Mar;13(3):247-53
references: 21289077